Statistics

Total Visits

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial8

Select a period of time:

Number of views in the range

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial4

Views

Views
November 20230
December 20231
January 20241
February 20240
March 20241
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
 

Top cities views

Views
Ashburn2
Chicago1